EntrepreneurialCheck
Ivan Vrkic estimated net worth profile

Ivan Vrkic net worth

Ivan Vrkic Net Worth 2026 (Estimated) · Co-Founder at CellType · YC W26
est. wealth $8.0M

Quick answer

Ivan Vrkic's estimated net worth is $8.0M (range $5.6M – $12.0M) as of 2026. Ivan Vrkic is Co-Founder at CellType. CellType valuation.

Ivan Vrkic is Co-Founder at CellType (YC W26). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameIvan Vrkic
RoleCo-Founder
CompanyCellType
YC batchW26
Est. company val$20.0M
Assumed ownership40%
Est. paper wealth / net worth$8.0M
$5.6M – $12.0M
  • Company status: Active
  • Region: United States of America
  • Industries: Healthcare, Drug Discovery and Delivery
  • Team size: 2
  • Website: https://www.celltype.com

Who is Ivan Vrkic?

Ivan Vrkic is a founder involved with CellType, an organization that participated in Y Combinator's W26 batch.

Highlights:

  • Y Combinator W26
  • CellType

About CellType

CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.

FAQ: Ivan Vrkic net worth and CellType valuation

What is Ivan Vrkic's net worth?

Ivan Vrkic's estimated net worth is $8.0M (range $5.6M – $12.0M) as of 2026. Ivan Vrkic is Co-Founder at CellType. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is CellType valuation?

CellType's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Ivan Vrkic's role?

Ivan Vrkic is Co-Founder at CellType, a Y Combinator-backed startup (batch W26).